Articles

A custom CRISPR solution

Engineered particles improve the efficiency of base editor delivery.
Written byAparna Nathan, PhD
| 3 min read
Illustration of hands using scissors and tweezers to cut and arrange strands of DNA.

Researchers at the Broad Institute just made gene editing a little easier using virus-like particles.

CREDIT: iStock/DrAfter123

Viruses have long been scientists’ unwitting vessels for moving genome editing machinery into cells. Now, they face new and improved competition: engineered virus-like particles, or eVLPs.

In a study recently published in Cell, researchers presented a souped-up version of a VLP — a non-infectious skeleton of a virus lacking a genome — that can be packed full of the proteins needed for genome editing (1). With careful optimization, they made the VLP better at delivering its cargo to cells, not only in a test tube, but also in living organisms.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Aparna Nathan Headshot

    Aparna is a freelance science writer pursuing a PhD in bioinformatics and genomics at Harvard University. She uses her multidisciplinary training to find both the cutting-edge science and the human stories in everything from genetic testing to space expeditions. She was recently a 2021 AAAS Mass Media Fellow at the Philadelphia Inquirer. Her writing has also appeared in Popular Science, PBS NOVA, and The Open Notebook.

    View Full Profile

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.